ニュース
Law Offices of Howard G. Smith reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Hims & Hers Health, Inc ...
15 時間on MSN
Find insight on Innovent Biologics, Fisher & Paykel Healthcare and more in the latest Market Talks covering Health Care.
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
22 時間
Zacks Investment Research on MSNHims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
Senate To Begin Marathon Vote Series On Trump's "Big, Beautiful Bill" As GOP Eyes July 4 Deadline The Senate is set to kick off what's expected to be a marathon session Monday, after the chamber ...
Weight Watchers is Novo Nordisk's latest partnersip.
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
今週の顧客向けノートで、Compass Pointは「ニュートラル」の評価と205ドルの目標株価でCRCLのカバレッジを開始した。同社は慎重な評価の理由として、規制されたステーブルコインにおけるリーダーシップと流通における課題の両方を指摘した。
Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する